ARTICLE: G. Grisay, F. Turco, A. Patrikidou, E. Gallardo Díaz, R. S. McDermott, S. Litiere, B. Fournier, S. Gillessen, B. F. Tombal (2024) EORTC GUCG 2238 De-escalate: A pragmatic trial to revisit intermittent androgen-deprivation therapy in metastatic hormone-naïve prostate cancer in the era of new AR pathway inhibitors. DOWNLOAD
To Be Updated Soon
© The DE-ESCALATE Consortium 2023-2028. This project has received funding from the European Union’s HORIZON-MISS-CANCER-2022-01 under grant agreement Nº (101104574 ). Views and opinions expressed are however those of the authors only and do not necessarily reflect those of the European Union. Neither the European Union nor the granting authority can be held responsible for them.
Copyright © 2024 All rights reserved.
